Hormone replacement therapy [topp]
Focus [spco]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
progesterone, micronized [horm, phsu, strd]
Original [idcn]
Conclusions [idcn]
Initiative [menp]
Study [mnob]
Question [inpr]
Availability [ftcn]
Age [orga]
Stratified [qlco]
Initial [tmco]
Concerns [idcn]
coronary heart disease [dsyn]
Association [menp]
Hormone replacement therapy [topp]
Replaced [ftcn]
Concerns [idcn]
Thromboembolic disease [dsyn]
Venous Thromboembolism [patf]
Young [tmco]
postmenopausal [tmco]
Women [popg]
Stroke [dsyn]
Old [tmco]
Women [popg]
Original [idcn]
Publication [inpr, mnob]
study results [fndg]
LED [mnob]
Decrease [qlco]
Oral [spco]
Hormone replacement therapy [topp]
Transdermal [ftcn]
Hormone replacement therapy [topp]
Increased [qnco]
Guidelines [inpr]
North American [fndg]
Menopause [phsf]
society [orgt]
Endocrine [bdsy]
society [orgt]
International [idcn]
Menopause [phsf]
society [orgt]
Specific [qlco]
Guidelines [inpr]
European [popg]
Menopause [phsf]
Andropause [fndg]
society [orgt]
Management [ocac]
Menopausal [phsf]
Women [popg]
Personal [orga]
Family history [fndg]
Venous Thromboembolism [patf]
Statement [idcn]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
progesterone, micronized [horm, phsu, strd]
Oral [spco]
Estrogens [horm, phsu, strd]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Venous Thromboembolism [patf]
Stroke [dsyn]
Doses [qnco]
mU/g [qnco]
Low Risk [fndg]
Gall Bladder Disease [dsyn]
Progestogens [horm, phsu, strd]
Progesterone [horm, phsu, strd]
Increased [qnco]
Venous Thromboembolism [patf]
Increased [qnco]
Breast Cancer [neop]
Based [ftcn]
Now [tmco]
included [ftcn]
Guidelines [inpr]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
progesterone, micronized [horm, phsu, strd]
Possibly [qlco]
Excess [qlco]
Venous Thromboembolism [patf]
Stroke [dsyn]
Cholecystitis [dsyn]
Possibly [qlco]
Breast Cancer [neop]
Oral use [ftcn]
Hormone replacement therapy [topp]
